2024-11-19 | Sale | Esperion Therapeutics, Inc. ESPR | Chief Commercial Officer | | $2.17 | $427 | +11.55% | |
2024-10-17 | Sale | Esperion Therapeutics, Inc. ESPR | Chief Commercial Officer | | $2.12 | $227 | +0.95% | |
2024-09-17 | Sale | Esperion Therapeutics, Inc. ESPR | Chief Commercial Officer | | $1.78 | $4,650 | +16.01% | |
2024-08-19 | Sale | Esperion Therapeutics, Inc. ESPR | Chief Commercial Officer | | $1.95 | $411 | +0.53% | |
2024-07-17 | Sale | Esperion Therapeutics, Inc. ESPR | Chief Commercial Officer | | $2.59 | $279 | -23.47% | |
2024-06-18 | Sale | Esperion Therapeutics, Inc. ESPR | Chief Commercial Officer | | $2.86 | $7,254 | -25.37% | |
2024-05-17 | Sale | Esperion Therapeutics, Inc. ESPR | Chief Commercial Officer | | $2.48 | $477 | -10.64% | |
2023-09-20 | Sale | Esperion Therapeutics, Inc. ESPR | Chief Commercial Officer | | $1.25 | $924 | +80.87% | |
2023-08-18 | Sale | Esperion Therapeutics, Inc. ESPR | Chief Commercial Officer | | $1.41 | $344 | +43.79% | |
2023-07-19 | Sale | Esperion Therapeutics, Inc. ESPR | Chief Commercial Officer | | $1.58 | $168 | +33.12% | |
2023-06-21 | Sale | Esperion Therapeutics, Inc. ESPR | Chief Commercial Officer | | $1.48 | $894 | +33.8% | |
2023-05-17 | Sale | Esperion Therapeutics, Inc. ESPR | Chief Commercial Officer | | $1.62 | $356 | -9.09% | |
2023-04-19 | Sale | Esperion Therapeutics, Inc. ESPR | Chief Commercial Officer | | $1.28 | $147 | +15.86% | |
2023-03-17 | Sale | Esperion Therapeutics, Inc. ESPR | Chief Commercial Officer | | $1.78 | $937 | -5.48% | |
2023-03-07 | Sale | Esperion Therapeutics, Inc. ESPR | Chief Commercial Officer | | $5.05 | $25,730 | -70.06% | |
2022-10-18 | Sale | Esperion Therapeutics, Inc. ESPR | Chief Commercial Officer | | $7.69 | $823 | -79.61% | |
2022-09-19 | Sale | Esperion Therapeutics, Inc. ESPR | Chief Commercial Officer | | $6.92 | $1,765 | -76.24% | |
2022-08-31 | Purchase | Esperion Therapeutics, Inc. ESPR | Chief Commercial Officer | | $7.46 | $7,460 | -29.89% | |
2022-08-17 | Sale | Esperion Therapeutics, Inc. ESPR | Chief Commercial Officer | | $6.82 | $1,356 | -18% | |
2022-07-19 | Sale | Esperion Therapeutics, Inc. ESPR | Chief Commercial Officer | | $6.58 | $2,837 | -7.94% | |